IFP Advisors’s Aura Biosciences AURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.21K Sell
192
-17
-8% -$122 ﹤0.01% 4434
2026
Q2
$1.48K Buy
209
+14
+7% +$100 ﹤0.01% 4368
2026
Q1
$1.3K Sell
195
-168
-46% -$964 ﹤0.01% 4113
2025
Q4
$1.98K Buy
363
+362
+36,200% +$2.15K ﹤0.01% 3847
2025
Q3
$6 Buy
+1
New +$7 ﹤0.01% 4797
2025
Q2
– Sell
-10
Closed -$58 – 4365
2025
Q1
$59 Hold
10
– – ﹤0.01% 3985
2024
Q4
$82 Buy
+10
New +$94 ﹤0.01% 4102

Other funds holding AURA

IFP Advisors's AURA Position: Q3 2026 in Review

IFP Advisors reduced its Aura Biosciences (AURA) stake by 8.1% in Q3 2026, selling an estimated $122 and leaving 192 shares worth $1.21K. The position accounts for ﹤0.01% of the portfolio, ranked #4434.

IFP Advisors first reported a position in AURA in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.98K in Q4 2025. 154 funds tracked by Wall St. Rank hold AURA as of Q3 2026.

  • IFP Advisors held 192 shares of Aura Biosciences worth $1.21K as of Q3 2026.
  • IFP Advisors sold 17 Aura Biosciences shares in Q3 2026, an estimated $122.
  • Aura Biosciences made up ﹤0.01% of IFP Advisors's portfolio in Q3 2026, its #4434 holding.
  • IFP Advisors first reported a position in Aura Biosciences in Q4 2024 and has held it in 7 quarters since.
  • IFP Advisors's Aura Biosciences position peaked at $1.98K in Q4 2025.
  • 154 funds tracked by Wall St. Rank held Aura Biosciences as of Q3 2026.

Based on IFP Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.